Cambridge Investment Research Advisors, Inc. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$339
-23.3%
21,362
-8.8%
0.00%0.0%
Q2 2023$442
+124.4%
23,433
-54.4%
0.00%
+100.0%
Q1 2023$197
-21.8%
51,401
+1.3%
0.00%0.0%
Q4 2022$252
-99.9%
50,765
-5.0%
0.00%0.0%
Q3 2022$256,000
+6.2%
53,463
-0.2%
0.00%0.0%
Q2 2022$241,000
+81.2%
53,563
+91.5%
0.00%0.0%
Q1 2022$133,000
-35.7%
27,974
+0.4%
0.00%0.0%
Q4 2021$207,000
+95.3%
27,875
+49.2%
0.00%0.0%
Q3 2021$106,000
-5.4%
18,687
+7.6%
0.00%0.0%
Q4 2020$112,000
+55.6%
17,373
-12.5%
0.00%
Q3 2020$72,000
-20.9%
19,866
+0.5%
0.00%
-100.0%
Q2 2020$91,000
+35.8%
19,7660.0%0.00%0.0%
Q1 2020$67,000
-75.5%
19,766
+7.7%
0.00%
-90.0%
Q1 2014$274,000
+21.2%
18,358
+19.1%
0.01%
+11.1%
Q4 2013$226,000
-9.6%
15,408
+4.8%
0.01%
-18.2%
Q3 2013$250,000
+8.2%
14,708
+5.8%
0.01%
-8.3%
Q2 2013$231,00013,9080.01%
Other shareholders
IMMUNOGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders